Medgene Receives Emergency Use Authorization for RHDV2 Vaccine
Rabbit Hemorrhagic Disease has quickly spread across the United States. Working with the USDA, Medgene Labs responds with a vaccine developed on its prescription platform technology. Medgene Labs, a vaccine and immunological services provider based in Brookings, SD, has received emergency use authorization for their experimental Rabbit Hemorrhagic Disease Virus 2 (RHDV2) vaccine from the … Continue reading Medgene Receives Emergency Use Authorization for RHDV2 Vaccine
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed